SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised FY2026 revenue outlook, attributed to stronger demand for Amtagvi and Proleukin, is driving the rally. Traders are largely bullish on the commercial momentum, while short-squeeze talk remains speculative and many are watching for upcoming lung cancer data.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is plunging after the FHFA moved to include VantageScore alongside FICO in Fannie Mae and Freddie Mac mortgage scoring, raising concerns that competition could erode FICOs pricing power and mortgage-market dominance. Traders are split between expecting further pressure on the business and viewing the selloff as an overreaction and a buying opportunity.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas selection for the U.S. Armys ALATTIS program to develop next-generation 10 kV silicon-carbide semiconductors is driving discussion. Bulls view the award as technology and domestic-manufacturing validation, while skeptics note it is a prototype program with undisclosed financial terms and no clear immediate revenue, fueling debate over the sharp reversal after the initial surge.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields surge amid concerns about persistent inflation, government borrowing and a higher-for-longer Fed path. Traders are largely focused on the bond selloff and warn of further downside, while others see the decline as oversold and are accumulating in anticipation of a rebound.

Carnival Corp. Ltd. engages in the operation of cruise ships. It operates through the following business segments: North America Cruise Operations, Europe Cruise Operations, Cruise Support, and Tour and Others. The North America Cruise Operations segment includes the Carnival Cruise Line, Holland America Line, Princess Cruises, and Seabourn. The Europe Cruise Operations segment consists of AIDA, Costa, Cunard, and P&O Cruises (UK). The Cruise Support segment represents port destinations and private islands for the benefit of its cruise brands. The Tour and Other segment operates hotel and transportation operations of Holland America Princess Alaska Tours. The company was founded in 1972 and is headquartered in Miami, FL.

Carnival Corporation Ltd.

Carnival Corp

Carnivals quarterly results beat expectations and the company raised its full-year outlook, with record bookings and pricing strengthening the demand outlook and fueling a sharp rally. Bulls are celebrating the results, while skeptics point to elevated fuel costs and softer near-term guidance as risks to whether the gains can hold.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Rising Treasury yields and persistent inflation concerns are weighing on rate-sensitive Russell 2000 small caps, which traders say are lagging large-cap tech as borrowing and refinancing costs rise. The discussion is broadly bearish, though some see the selloff as oversold and look for a rebound if yields ease.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles sharp rebound has traders pointing to its new agentic-AI products, OpenAIs reported revenue momentum and cloud partnerships as support for its AI growth story. Bullish posts describe a possible short squeeze, while skeptics question whether the gains will hold amid volatility and debt concerns.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and concern that interest rates may stay higher are weighing on SPY, with traders debating whether bond-market pressure will deepen the equity selloff. The conversation is split between bearish calls and dip-buyers, amid especially choppy index trading.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

AstraZenecas $2 billion strategic investment in Summit and clinical collaboration on ivonescimab are driving attention, with traders viewing the deal as financing support and a vote of confidence. Some remain cautious about dilution and stress that the investment is not a buyout or a guarantee of FDA approval.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Jobys Texas eIPP flights and autonomous-flight demonstrations are fueling discussion about progress toward FAA certification and eventual commercialization. Optimists see these milestones and defense opportunities as long-term positives, while skeptics focus on the stocks steep decline, insider selling, dilution risk and continued cash burn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Dolby Expands Meta Partnership With Atmos and Vision Across Devices

DLB expands across Meta's ecosystem as Dolby Atmos and Vision reach AI glasses, Instagram and VR, broadening its digital content footprint.


Meta AI Glasses To Record Audio In Dolby Atmos

(RTTNews) - Dolby Laboratories (DLB) and Meta (META) announced the expansion of Dolby experiences within the Meta ecosystem of devices and platforms. Meta AI glasses are the first global consumer device capable of capturing audio in Dolby Atmos. Users can capture their favorite m...

Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem

Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's Ecosystem Dolby and Meta Expand Dolby Atmos and Dolby Vision Across Meta's EcosystemPR NewswireSAN FRANCISCO and MENLO PARK, Calif., Sept. 23, 2026 Across Meta AI glasses, Instagram, and VR devices, Dolby Atmos and Dolby Vision bring...

Here's Why the Fund Exits Dolby Laboratories (DLB)

Here's Why the Fund Exits Dolby Laboratories (DLB...

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan

Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock Plan Dolby Laboratories, Inc. Grants Inducement Equity Awards Under Its 2026 Inducement Stock PlanPR NewswireSAN FRANCISCO, Sept. 15, 2026 SAN FRANCISCO, Sept. 15, 2026 /PRNewswire/ -- Dolby Laboratories, Inc...

Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026

Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026 Dolby Expands Dolby OptiView Platform with New Capabilities at IBC 2026 PR Newswire AMSTERDAM, Sept. 10, 2026 New Sports Intelligence helps providers better understand and deepen fan engagement, as Dolby Vision comes to the...

Dolby Laboratories (DLB) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Industry Outlook Highlights Sony, Dolby Laboratories and Sonos

Sony, Dolby Laboratories and Sonos navigate audio-video headwinds with technology, gaming, immersive media and product innovation.

3 Audio Video Stocks to Watch as the Industry Grapples With Headwinds

Amid cautious discretionary spending and macro troubles, investments in cutting-edge solutions are likely to aid Zacks Audio Video Production industry participants like SONY, DLB and SONO.

Dolby Laboratories (DLB) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Dolby Laboratories, Inc. engages in the provision of audio and imaging technologies. It focuses on licensing audio and video technologies to electronic manufacturers. The company was founded by Ray Milton Dolby in 1965 and is headquartered in San Francisco, CA.

Dolby Laboratories Inc - Ordinary Shares - Class A

Dolby Stock In Focus As Google-Samsung Prepare Free Rival to Atmos 3D Audio Tech; Alphabet Faces Retail Pushback

Equity

Neutral Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Feed

News

Sentiment

Earnings

Fundamentals

Info

DLB Dolby Laboratories Inc - Ordinary Shares - Class A

Fundamentals

Latest DLB News